Liabilities / Assets
33rd percentile
Higher debt load relative to assets than 33% of similar nonprofits.
I2B2 Transmart Foundation
990 • Fiscal year 2023 • EIN 80-0912629
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.02x
Liabilities / Revenue
32nd percentile
Higher debt load relative to revenue than 32% of similar nonprofits.
Net Margin
86th percentile
Higher net margin than 86% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
83rd percentile
Faster asset growth than 83% of similar nonprofits.
Revenue Growth
98th percentile
Faster revenue growth than 98% of similar nonprofits.
Balance Sheet
Assets
Up$2,170,821
Up $487,325 (+29%) from 2022
Net Assets
Up$2,136,855
Up $499,072 (+30%) from 2022
Liabilities
Down$33,966
Down $11,747 (-26%) from 2022
Revenue And Expenses
Revenue
Up$1,414,045
Up $1,098,426 (+348%) from 2022
Expenses
Down$914,973
Down $23,623 (-2.5%) from 2022
Net Income
Up$499,072
Up $1,122,049 (+180%) from 2022
Historical Trend
Filing Detail Status
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2022 to Jun 30, 2023
Mission and Program Overview
Mission
The i2b2 transmart foundation enables effective collaboration for precision medicine, through the sharing, integration, standardization and analysis of heterogenous data from healthcare and research; through engagement and mobilization of a life sciences focused open-source, open-data community.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $2,170,821
- Liabilities
- $33,966
- Net assets
- $2,136,855
- Revenue
- $1,414,045
- Expenses
- $914,973
- Net income
- $499,072